The Big Pharma company has reached an A$300 million ($204.8 million) class action settlement over defective pelvic mesh implants given to Australian women in what is the country’s largest ever product-liability settlement.
This follows court proceedings with more than 11,000 claimants who have complained of urinary problems, bleeding and other serious injuries from the implants, and similar previous lawsuits in the US, Canada and Europe.
Monday’s settlement also comes after an Australian federal court judge had previously found that J&J subsidiary Ethicon had sold the implants without warning women and surgeons of the risks.